A total score was calculated using age at the diagnosis of breast cancer, received NACT or not, pathology types, tumor size, number of positive lymph nodes, HR status, HER-2 status, type of initial breast operation, DFI, and location of LRR. This evidence concerns the gene ERBB2 and breast cancer.